Geoff MacKay Overview
Geoff MacKay General Information
Biography
Mr. Geoff MacKay served as Board Member at Gemstone Biotherapeutics. Mr. Geoff MacKay serves as Independent Director at Replicel Life Sciences. He served as Partner at Proteus (Portola Valley). Previously, he was a Co-Founder and served as the President, Chief Executive Officer, and Board Member at Avrobio. He served as an Advisor at Atlas Venture. He serves as a Board Member at Talaris Therapeutics. He is an experienced CEO with proven success in leading innovative businesses. While CEO of Organogenesis Inc., the company treated 1 million patients with living cell therapies, received the first FDA CBER allogeneic cell-therapy approval, and achieved an unparalleled position within regenerative medicine. He was the founding CEO of eGenesis, applying CRISPR Cas-9 gene editing to xenotransplantation. He spent 11 years at Novartis in senior leadership positions within the Global Transplantation & Immunology franchise. Past activities include Chairman of the Board of MassBio, Chairman of the Board of the Alliance of Regenerative Medicine, and Advisory Council to the Health Policy Commission for Massachusetts. Through his public and private enterprise work, he is dedicated to applying innovation to reshape and improve the quality of healthcare.
Contact Information
Address
- 405 Waltham Street
- Suite 337
- Lexington, MA 02421-7934
- United States
Geoff MacKay Board Seats (3)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| RedactBio | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Lexington, MA | |
| Replicel Life Sciences | Drug Discovery | Publicly Held | Corporation | Vancouver, Canada | |
| Talaris Therapeutics | Biotechnology | Acquired/Merged | Formerly VC-backed | Louisville, KY |
Geoff MacKay Lead Partner on Deals (1)
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| NanoMatrix | 25-Feb-2008 | Merger/Acquisition | Completed | Biotechnology | Baton Rouge, LA |
Geoff MacKay Network (17)
Board Members (14)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Nicholas Galakatos Ph.D | Talaris Therapeutics | Blackstone Life Sciences | Louisville, KY | 0000-00-00 |
| Andrew Schutte | Replicel Life Sciences | Replicel Life Sciences | Vancouver, Canada | 0000-00-00 |
| 00000 00000 | Talaris Therapeutics | Self | Louisville, KY | 0000-00-00 |
| 000000 0000 | Talaris Therapeutics | Self | Louisville, KY | 0000-00-00 |
| 00000 0000 | Replicel Life Sciences | Self | Vancouver, Canada | 0000-00-00 |
Portfolio Executives (3)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| William Fioretti Ph.D | NanoMatrix | Co-Owner, President & Chairman | 25-Feb-2008 | Baton Rouge, LA |
| Gary Bowlin Ph.D | NanoMatrix | Co-Founding Inventor | 25-Feb-2008 | Baton Rouge, LA |
| 0000 0000 | NanoMatrix | Co-Founding Investor | 25-Feb-2008 | Baton Rouge, LA |
Geoff MacKay FAQs
-
Who is Geoff MacKay?
Mr. Geoff MacKay served as Board Member at Gemstone Biotherapeutics.
-
How much does Geoff MacKay typically invest?
Geoff MacKay's median deal size is 000000.
-
What is Geoff MacKay’s main position?
Geoff MacKay’s primary position is Board Member.
-
How many active board seats does Geoff MacKay hold?
Geoff MacKay holds 3 board seats including RedactBio, Replicel Life Sciences, and Talaris Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
